Combined Therapeutics has a total of 48 patents globally, out of which 7 have been granted. Of these 48 patents, more than 83% patents are active. Europe (EPO) is where Combined Therapeutics has filed the maximum number of patents, followed by USA and Japan. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Combined Therapeutics.
Combined Therapeutics was founded in 2016. Combined Therapeutics is a pioneering biotech focused on advancing immunotherapy for cancer treatment at the pre-clinical stage, aiming to revolutionize cancer care.
Do read about some of the most popular patents of Combined Therapeutics which have been covered by us in this article and also you can find Combined Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Combined Therapeutics patent portfolio.
How many patents does Combined Therapeutics have?
Combined Therapeutics has a total of 48 patents globally. These patents belong to 2 unique patent families. Out of 48 patents, 40 patents are active.
How Many Patents did Combined Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Combined Therapeutics Applications Filed | Combined Therapeutics Patents Granted |
| 2023 | 5 | 6 |
| 2022 | 5 | 1 |
| 2021 | 16 | – |
| 2020 | 4 | – |
| 2019 | 7 | – |
| 2018 | 11 | – |
How many Combined Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Combined Therapeutics File in Different Countries?
Countries in which Combined Therapeutics Filed Patents
| Country | Patent |
| Europe | 6 |
| United States Of America | 5 |
| Japan | 5 |
| Canada | 4 |
| Australia | 4 |
| Mexico | 4 |
| Singapore | 2 |
| Hong Kong (S.A.R.) | 2 |
| South Africa | 2 |
| India | 2 |
| Israel | 2 |
| Brazil | 1 |
| Poland | 1 |
| Spain | 1 |
| Portugal | 1 |
| Austria | 1 |
| Italy | 1 |
Where are Research Centers of Combined Therapeutics Patents Located?
What Percentage of Combined Therapeutics US Patent Applications Were Granted?
Combined Therapeutics (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100%.
Below are the key stats of Combined Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Combined Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Dla Piper Llp Us | 2 | 100% |
List of Combined Therapeutics patents
| Combined Therapeutics Patents | Title |
| US11596685B2 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| US11359212B2 | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue |
| US20230241206A1 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| US20220220506A1 | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue |
| US20200376142A1 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| EP3678673B1 | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue |
| EP4218770A3 | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue |
| EP4188393A1 | Compositions And Methods For Improved Vaccination |
| EP4106770A1 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| EP4008333A1 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| EP3755344A1 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| PL3678673T3 | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue |
| ES2942890T3 | Compositions And Methods For Targeted Delivery, Expression And Modulation Of Encoding Ribonucleic Acids In Tissues |
| IT202300019191T2 | Compositions And Procedures For The Administration, Expression And Targeted Modulation Of Ribonucleic Acids Coding In The Tissue. |
| PT3678673T | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue |
| JP2023536844A | Compositions And Methods For Improving Vaccination |
| JP2023514594A | Compositions And Methods For Organ-Protective Expression And Regulation Of Encoded Ribonucleic Acids |
| MX2023001187A | Compositions And Methods For Improved Vaccination |
| AU2021326420A1 | Compositions And Methods For Improved Vaccination |
| MX2022010084A | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids. |
| AU2021224990A1 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| CA3187345A1 | Compositions And Methods For Improved Vaccination |
| CA3168048A1 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| MX2020008606A | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids. |
| MX2020002568A | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue. |
| AU2019221826A1 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| AU2018328289A1 | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue |
| CA3091543A1 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| CA3074293A1 | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue |
| ZA202208795B | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| IN202327005521A | Compositions And Methods For Improved Vaccination |
| HK40022397A1 | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue |
| IL300247A | Compositions And Methods For Improved Vaccination |
| SG11202300677UA | Compositions And Methods For Improved Vaccination |
| ZA202301219A | Compositions And Methods For Improved Vaccination |
| IN202227052816A | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| IL295724A | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| SG11202251944HA | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| HK40035129A | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| BR112023001563A2 | Compositions And Methods For Improved Vaccination |
| AT1545499T | Zusammensetzungen Und Verfahren Zur Gezielten Abgabe, Expression Und Modulation Codierender Ribonukleinsäuren In Gewebe |
| WO2022035621A1 | Compositions And Methods For Improved Vaccination |
| WO2021168405A1 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| WO2019158955A9 | Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids |
| WO2019051100A1 | Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue |
| JP2023159160A | Compositions And Processes For Targeted Delivery, Expression And Regulation Of Encoded Ribonucleic Acids In Tissues |
| JPWO2019158955A5 | Compositions And Methods For Organ-Protective Expression And Regulation Of Encoded Ribonucleic Acids |
| JP2020533411A5 | Compositions And Processes For Targeted Delivery, Expression And Regulation Of Encoded Ribonucleic Acids In Tissues |
What are Combined Therapeutics key innovation segments?
What Technologies are Covered by Combined Therapeutics?
The chart below distributes patents filed by Combined Therapeutics